204 related articles for article (PubMed ID: 23588954)
1. Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship.
Sheppard VB; Isaacs C; Luta G; Willey SC; Boisvert M; Harper FW; Smith K; Horton S; Liu MC; Jennings Y; Hirpa F; Snead F; Mandelblatt JS
Breast Cancer Res Treat; 2013 May; 139(1):207-16. PubMed ID: 23588954
[TBL] [Abstract][Full Text] [Related]
2. Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
Sheppard VB; de Mendoza AH; He J; Jennings Y; Edmonds MC; Oppong BA; Tadesse MG
Clin Breast Cancer; 2018 Oct; 18(5):337-346.e1. PubMed ID: 29422259
[TBL] [Abstract][Full Text] [Related]
3. Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer.
Nurgalieva ZZ; Franzini L; Morgan RO; Vernon SW; Liu CC; Du XL
Med Oncol; 2013 Mar; 30(1):419. PubMed ID: 23292872
[TBL] [Abstract][Full Text] [Related]
4. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
[TBL] [Abstract][Full Text] [Related]
5. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
6. Disparities in breast cancer surgery delay: the lingering effect of race.
Sheppard VB; Oppong BA; Hampton R; Snead F; Horton S; Hirpa F; Brathwaite EJ; Makambi K; Onyewu S; Boisvert M; Willey S
Ann Surg Oncol; 2015 Sep; 22(9):2902-11. PubMed ID: 25652051
[TBL] [Abstract][Full Text] [Related]
7. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
[TBL] [Abstract][Full Text] [Related]
8. Assessing Perceived Discrimination as Reported by Black and White Women Diagnosed with Breast Cancer.
Sutton AL; Hagiwara N; Perera RA; Sheppard VB
J Racial Ethn Health Disparities; 2021 Jun; 8(3):589-595. PubMed ID: 32808196
[TBL] [Abstract][Full Text] [Related]
9. Narrowing Racial Gaps in Breast Cancer: Factors Affecting Probability of Adjuvant Radiation Therapy.
Snead F; Slade AN; Oppong BA; Sutton AL; Sheppard VB
Adv Radiat Oncol; 2020; 5(1):17-26. PubMed ID: 32051886
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ
J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in receipt of adjuvant hormonal therapy among Medicaid enrollees in South Carolina diagnosed with breast cancer.
Felder TM; Do DP; Lu ZK; Lal LS; Heiney SP; Bennett CL
Breast Cancer Res Treat; 2016 May; 157(1):193-200. PubMed ID: 27120468
[TBL] [Abstract][Full Text] [Related]
12. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
13. A tracking and feedback registry to reduce racial disparities in breast cancer care.
Bickell NA; Shastri K; Fei K; Oluwole S; Godfrey H; Hiotis K; Srinivasan A; Guth AA
J Natl Cancer Inst; 2008 Dec; 100(23):1717-23. PubMed ID: 19033569
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
[TBL] [Abstract][Full Text] [Related]
15. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.
Fedewa SA; Ward EM; Stewart AK; Edge SB
J Clin Oncol; 2010 Sep; 28(27):4135-41. PubMed ID: 20697082
[TBL] [Abstract][Full Text] [Related]
16. Exploring Racial Differences in Patient Centeredness of Care (PCC) During Breast Cancer (BC) Chemotherapy Clinical Visits.
Robertson-Jones TA; Tissue MM; Connolly M; Gallups SF; Bender CM; Rosenzweig MQ
J Racial Ethn Health Disparities; 2019 Feb; 6(1):94-100. PubMed ID: 29971577
[TBL] [Abstract][Full Text] [Related]
17. Residual treatment disparities after oncology referral for rectal cancer.
Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer.
Reeder-Hayes KE; Meyer AM; Dusetzina SB; Liu H; Wheeler SB
Breast Cancer Res Treat; 2014 Jun; 145(3):743-51. PubMed ID: 24789443
[TBL] [Abstract][Full Text] [Related]
19. Reducing Racial Disparities in Breast Cancer Survivors' Ratings of Quality Cancer Care: The Enduring Impact of Trust.
Sheppard VB; Hurtado-de-Mendoza A; Talley CH; Zhang Y; Cabling ML; Makambi KH
J Healthc Qual; 2016; 38(3):143-63. PubMed ID: 27152910
[TBL] [Abstract][Full Text] [Related]
20. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer.
Sail K; Franzini L; Lairson D; Du X
Ethn Health; 2012; 17(3):309-23. PubMed ID: 22066691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]